Laura Elias
Laura Elias is a distinguished alumna of the University of California, San Francisco, where she specialized in neuroscience. Currently, she serves as the Head of Commercial for neurology, pediatric, metabolic, and rare disease genetic testing at Invitae. Her role is pivotal in shaping the strategic direction and commercial success of the company's genetic testing services. Laura's unique blend of scientific expertise and business strategy, honed through her experience at the Boston Consulting Group, enables her to effectively lead her team in expanding testing volumes through innovative strategies, partnerships, and marketing initiatives. Her career is marked by a seamless integration of her passion for neuroscience with her keen interest in business strategy and marketing. Laura's journey is a testament to her commitment to continuous learning and her adept problem-solving capabilities. She attributes much of her professional growth to the mentorship of Arnold Kriegstein, whose guidance has been instrumental in her career development. This mentorship has not only enriched her understanding of neuroscience but also inspired her to explore diverse career paths. Laura's ability to learn quickly, coupled with her independence and creativity, has been central to her success. Her career trajectory is a reflection of the diverse opportunities available to UCSF alumni, highlighting the university's supportive environment that fosters career growth and development. Her work at Invitae is a perfect example of how scientific knowledge can be leveraged to create impactful business strategies in the healthcare industry. In her role, Laura is dedicated to advancing the field of genetic testing, particularly in areas that have significant implications for patient care and treatment outcomes. Her leadership is characterized by a forward-thinking approach that seeks to bridge the gap between scientific innovation and market needs. Laura's efforts are not only enhancing the reach of genetic testing but also contributing to the broader understanding of its importance in personalized medicine. Laura's career is a vivid illustration of how a strong foundation in neuroscience, combined with strategic business insights, can lead to impactful contributions in the field of genetic testing. Her work continues to inspire those around her, as she navigates the complexities of the healthcare market with a clear vision and unwavering dedication.
Publications
, 7072-7077, 2010-05-19
, 3805-3810, 2010-02-23
, 95-100, 2019-11-29
, 127-134, 2018-11-28
, 63-90, 2022-08-22
, 163-176, 2017-07-14
, 2022-08-18